Skip to main content
Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
81 PERFORMANCE OF QUERCETIN-CHITOSAN GELS AS TOPICAL DELIVERY SYSTEMS 2019
82 Development of Bi-Polymer Lipid Hybrid Nanocarrier (BLN) to Improve the Entrapment and Stability of Insulin for Efficient Oral Delivery 2019
83 A Multifunctional Lipid-based Nanodevice for the Highly-specific Co-delivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells 2019
84 A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation 2019
85 Self-Assembled Tannic Acid Complexes for pH-Responsive Delivery of Antibiotics: Role of Drug-Carrier Interactions 2019
86 Development and Evaluation of in-situ Nasal Gel
Formulations of Nanosized Transferosomal
Sumatriptan: Design, Optimization, in vitro and
in vivo Evaluation
2019
87 Development of Bi-Polymer Lipid Hybrid Nanocarrier (BLN) to Improve the Entrapment and Stability of Insulin for Efficient Oral Delivery 2019
88 Role of Self-Emulsifying Drug Delivery Systems in Optimizing the Oral Delivery of Hydrophilic Macromolecules and Reducing Interindividual Variability 2018
89 Self-Emulsifying Drug-Delivery Systems Modulate P-Glycoprotein Activity: Role of Excipients and Formulation Aspects 2018
90 Nanostructured Lipid Carriers for Improved Oral Delivery and Prolonged Antihyperlipidemic Effect of Simvastatin 2018